5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial

J Invest Dermatol. 2017 Jun;137(6):1367-1370. doi: 10.1016/j.jid.2016.12.029.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Cutaneous
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / pathology
  • Female
  • Fluorouracil / administration & dosage*
  • Follow-Up Studies
  • Humans
  • Keratosis, Actinic / drug therapy*
  • Keratosis, Actinic / pathology
  • Male
  • Precancerous Conditions / drug therapy*
  • Precancerous Conditions / pathology
  • Quality of Life
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil

Associated data

  • ClinicalTrials.gov/NCT00847912